NCT07355790

Brief Summary

The spine is the central musculoskeletal system of the back. It carries and supports a major part of the body weight and ensures simultaneously the trunk's mobility, particularly the mobility of the lumbar spine and the head's mobility by moving the cervical spine. Back pain in the lumbar spine area is the most common kind of pain with a prevalence of 60 to 70 per cent in industrialized countries (Jellema2001).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
18mo left

Started Dec 2025

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Dec 2025Nov 2027

First Submitted

Initial submission to the registry

November 27, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

December 9, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

1.9 years

First QC Date

November 27, 2025

Last Update Submit

February 2, 2026

Conditions

Keywords

Lumbar beltback insertconfort

Outcome Measures

Primary Outcomes (1)

  • Comfort

    Comfort is measuring with a scale : 0 = uncomfortable, 10 = extremely comfortable

    Day1

Study Arms (3)

Experimental group with additional back insert of a lumbar belt

EXPERIMENTAL

Additional back insert of a lumbar belt

Device: MRI evening 1

Control group with lumbar belt

ACTIVE COMPARATOR

a lumbar belt

Device: MRI evening 2

Control group without lumbar belt

SHAM COMPARATOR

without lumbar belt

Device: MRI

Interventions

MRIDEVICE

MRI in the evening without lumbar belt

Control group without lumbar belt

MRI in the evening after wearing the lumbar belt for one day

Control group with lumbar belt

MRI in the evening after wearing the lumbar belt with additional back insert for one day

Experimental group with additional back insert of a lumbar belt

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy volunteer, men or women, aged 18 to 50 years old without lumbar pathology.
  • Volunteer beneficiary of a social security scheme.
  • Volunteer informed about the study and having co-signed a consent form to participate to the study with the investigator

You may not qualify if:

  • Protected persons
  • Pregnant or breastfeeding women
  • Persons deprived of freedom, hospitalised without consent, hospitalised with other ends then research.
  • Adults under legal protection (protection of vulnerable adults) or not able to express consent.
  • Persons showing gait difficulties (test on treadmill) or with neurological/joint pathologies promoting falls (Parkinson, hemiplegia, …)
  • Patient suffering from scoliosis
  • Refusal of consent
  • Contraindication to MRI
  • Patient carrying an internal electronic device (pacemaker, neurostimulator, insulin pump…)
  • Patient with known allergies to one of the product components (e.g. latex)
  • During the first MRI, volunteers showing prior signs of lower back pain or discopathy will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Saint Etienne

Saint-Etienne, 42100, France

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hubert MAROTTE, MD PhD

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2025

First Posted

January 21, 2026

Study Start

December 9, 2025

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

February 4, 2026

Record last verified: 2026-02

Locations